These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13638834)

  • 1. Phenethylbiguanide in diabetic patients; clinical and metabolic effects.
    LAMBERT TH
    Calif Med; 1959 Apr; 90(4):257-60. PubMed ID: 13638834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LONG-TERM CHLORPROPAMIDE THERAPY IN DIABETES: FOUR YEARS' EXPERIENCE.
    EVANS JR; EVANS BR; EVANS GR
    J Am Geriatr Soc; 1964 Feb; 12():195-201. PubMed ID: 14118834
    [No Abstract]   [Full Text] [Related]  

  • 3. PHENFORMIN IN WEIGHT REDUCTION OF OBESE DIABETICS.
    PATEL DP; STOWERS JM
    Lancet; 1964 Aug; 2(7354):282-4. PubMed ID: 14163667
    [No Abstract]   [Full Text] [Related]  

  • 4. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 5. [MEDICAL TREATMENT OF DIABETES MELLITUS, INCLUDING DIET THERAPY].
    KOSAKA K; AKANUMA Y
    Naika; 1964 Apr; 13():716-23. PubMed ID: 14151352
    [No Abstract]   [Full Text] [Related]  

  • 6. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin.
    Abramson E; Arky RA
    Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.
    Umpierrez GE; Clark WS; Steen MT
    Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide.
    Raptis AE; Tountas N; Yalouris AG; Hadjidakis D; Zaharis A; Miras K; Raptis SA
    Acta Diabetol Lat; 1990; 27(1):11-22. PubMed ID: 2110711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of phenethylbiguanide (phenformin) in man. III. interrelationship between ethanol and phenethylibiguanide (PBG) in normal and diabetic subjects.
    Wajchenberg BL; Halpern A; Leme CE; Lerário AC; Silveria AA; Fioratti PA; Cesar FP
    Metabolism; 1976 Sep; 25(9):957-71. PubMed ID: 958002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of long-acting phenformin (DBI-TD) with insulin in insulin-dependent diabetes.
    FABRYKANT M; ASHE BI
    Metabolism; 1961 Sep; 10():684-8. PubMed ID: 13891252
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with phenylethylbiguanide (DBI) tablets and timed-disintegration capsules (DBI-TD) administered as an adjunct to insulin or sulfonylurea drugs in previously treated diabetic patients.
    Jakobson T; Kahanpää A; Berglund B
    Ann Med Intern Fenn; 1965; 54(3):109-16. PubMed ID: 5854020
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with DBI (phenformin) in the management of diabetes.
    McKENDRY JB; KUWAYTI K; RADO PP
    Can Med Assoc J; 1959 May; 80(10):773-8. PubMed ID: 13652024
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of action of phenethylbiguanide (Phenformin) in man IV. Effect of phenethylbiguanide (PBG) on glucose tolerance and lactate dynamics in obese nondiabetic and chemical diabetic subjects.
    Cesar FP; Leme CE; Ohnuma LY; Palomino CR; Wajchenberg BL
    Metabolism; 1980 Mar; 29(3):270-8. PubMed ID: 6990168
    [No Abstract]   [Full Text] [Related]  

  • 15. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin therapy of type 2 diabetes: from simple to flexible--three strategies are available].
    Liebl A
    MMW Fortschr Med; 2012 Nov; 154 Spec No 3():66-71; quiz 72-3. PubMed ID: 23724722
    [No Abstract]   [Full Text] [Related]  

  • 17. Placebo-controlled study with phenformin (DBI) in diabetic children.
    DITURI B; MOSIER HD
    J Am Med Womens Assoc; 1961 Dec; 16():939-41. PubMed ID: 13886610
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of diabetes in the adult with phenformin (DBI). 202 cases treated in an ambulatory therapeutic trial in a 3-year period].
    LISBOA PE; CASTEL-BRANCO N; MARQUES MM; ARROBAS MJ; FERREIRA FM; BARROS Q
    J Med (Oporto); 1962 Apr; 47():914-24 concl. PubMed ID: 14465774
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of phenformin (phenylethylbiguanide or DBI) on organo-aciduria in diabetics (Preliminary note)].
    HALPERN MJ; LISBOA PA
    J Soc Cienc Med Lisb; 1960 Nov; 124():770-8. PubMed ID: 13710919
    [No Abstract]   [Full Text] [Related]  

  • 20. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
    Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.